Nalaganje...
Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
Inflammatory bowel disease (IBD), in particular Crohn’s disease refractory to conventional therapy, fistulizing Crohn’s disease and chronic active ulcerative colitis, generally respond well to anti-tumor necrosis factor (TNF) therapy. However, serious side effects do occur, necessitating careful mon...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The WJG Press and Baishideng
2009
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2678575/ https://ncbi.nlm.nih.gov/pubmed/19418577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.2067 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|